Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL.

Favre R, Manzoni D, Traverse-Glehen A, Verney A, Jallades L, Callet-Bauchu E, Sujobert P, Salles G, Baseggio L.

Int J Lab Hematol. 2018 Apr 16. doi: 10.1111/ijlh.12824. [Epub ahead of print] No abstract available.

PMID:
29659173
2.

Knockdown of Human AMPK Using the CRISPR/Cas9 Genome-Editing System.

Grenier A, Sujobert P, Olivier S, Guermouche H, Mondésir J, Kosmider O, Viollet B, Tamburini J.

Methods Mol Biol. 2018;1732:171-194. doi: 10.1007/978-1-4939-7598-3_11.

PMID:
29480475
3.

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

Huet S, Tesson B, Jais JP, Feldman AL, Magnano L, Thomas E, Traverse-Glehen A, Albaud B, Carrère M, Xerri L, Ansell SM, Baseggio L, Reyes C, Tarte K, Boyault S, Haioun C, Link BK, Feugier P, Lopez-Guillermo A, Tilly H, Brice P, Hayette S, Jardin F, Offner F, Sujobert P, Gentien D, Viari A, Campo E, Cerhan JR, Salles G.

Lancet Oncol. 2018 Apr;19(4):549-561. doi: 10.1016/S1470-2045(18)30102-5. Epub 2018 Feb 20.

PMID:
29475724
4.

Case report: Purulent transformation of granulocytic sarcoma: An unusual pattern of differentiation in acute promyelocytic leukemia.

Collinge E, Tigaud I, Balme B, Gerland LM, Sujobert P, Carlioz V, Salles G, Thomas X, Paubelle E.

Medicine (Baltimore). 2018 Feb;97(8):e9657. doi: 10.1097/MD.0000000000009657.

5.

When it rains, it pours.

Degaud M, Sujobert P.

Blood. 2018 Feb 15;131(7):836. doi: 10.1182/blood-2017-10-814087. No abstract available.

PMID:
29449304
6.

From genetics to the clinic: a translational perspective on follicular lymphoma.

Huet S, Sujobert P, Salles G.

Nat Rev Cancer. 2018 Apr;18(4):224-239. doi: 10.1038/nrc.2017.127. Epub 2018 Feb 9. Review.

PMID:
29422597
7.

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia.

Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, Tigaud I, Pages MP, Chelghoum Y, Baracco F, Labussierre H, Ducastelle S, Paubelle E, Nicolini FE, Elhamri M, Campos L, Plesa C, Morisset S, Salles G, Bertrand Y, Michallet M, Thomas X.

World J Stem Cells. 2017 Dec 26;9(12):227-234. doi: 10.4252/wjsc.v9.i12.227.

8.

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets.

Bolen CR, McCord R, Huet S, Frampton GM, Bourgon R, Jardin F, Dartigues P, Punnoose EA, Szafer-Glusman E, Xerri L, Sujobert P, Salles G, Venstrom JM.

Blood Adv. 2017 Sep 27;1(22):1884-1890. doi: 10.1182/bloodadvances.2016000786. eCollection 2017 Oct 10.

9.

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

Hospital MA, Jacquel A, Mazed F, Saland E, Larrue C, Mondesir J, Birsen R, Green AS, Lambert M, Sujobert P, Gautier EF, Salnot V, Le Gall M, Decroocq J, Poulain L, Jacque N, Fontenay M, Kosmider O, Récher C, Auberger P, Mayeux P, Bouscary D, Sarry JE, Tamburini J.

Leukemia. 2018 Mar;32(3):597-605. doi: 10.1038/leu.2017.284. Epub 2017 Sep 15.

PMID:
28914261
10.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A.

Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.

11.

Morphologic features of μ-heavy-chain disease.

Courtois L, Sujobert P.

Blood. 2017 Jul 27;130(4):558. doi: 10.1182/blood-2017-04-781344. No abstract available.

PMID:
28751360
12.

Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature.

Quintela A, Sujobert P, Tigaud I, Hayette S, Ffrench M, Salles G, Thomas X, Plesa A.

Oncol Ther. 2017;5(1):111-118. doi: 10.1007/s40487-017-0041-7. Epub 2017 Feb 9.

13.

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Tesson B, Huet S, Grange B, Jallades L, Baseggio L, Felman P, Traverse-Glehen A, Magaud JP, Lega JC, Bole-Feysot C, Salles G, Callet-Bauchu E, Sujobert P.

Blood. 2017 Sep 7;130(10):1267-1269. doi: 10.1182/blood-2017-03-776674. Epub 2017 Jul 5. No abstract available.

PMID:
28679739
14.

Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.

Grange B, Callet-Bauchu E, Salles G, Sujobert P.

Expert Rev Mol Diagn. 2017 Jun;17(6):623-632. doi: 10.1080/14737159.2017.1327811. Epub 2017 May 15. Review.

PMID:
28480776
15.

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.

Poulain L, Sujobert P, Zylbersztejn F, Barreau S, Stuani L, Lambert M, Palama TL, Chesnais V, Birsen R, Vergez F, Farge T, Chenevier-Gobeaux C, Fraisse M, Bouillaud F, Debeissat C, Herault O, Récher C, Lacombe C, Fontenay M, Mayeux P, Maciel TT, Portais JC, Sarry JE, Tamburini J, Bouscary D, Chapuis N.

Leukemia. 2017 Nov;31(11):2326-2335. doi: 10.1038/leu.2017.81. Epub 2017 Mar 10.

PMID:
28280275
16.

BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.

Huet S, Szafer-Glusman E, Tesson B, Xerri L, Fairbrother WJ, Mukhyala K, Bolen C, Punnoose E, Tonon L, Chassagne-Clément C, Feugier P, Viari A, Jardin F, Salles G, Sujobert P.

Am J Hematol. 2017 Jun;92(6):515-519. doi: 10.1002/ajh.24701. Epub 2017 Mar 24.

PMID:
28247997
17.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Davé SS.

Cancer Discov. 2017 Apr;7(4):369-379. doi: 10.1158/2159-8290.CD-16-0330. Epub 2017 Jan 25.

18.

Ibrutinib-Induced Lymphocytosis: Cytological Features.

Quintela A, Sujobert P, Callet-Bauchu E, Salles G, Baseggio L.

Acta Haematol. 2017;137(1):55-57. doi: 10.1159/000452437. Epub 2016 Dec 14. No abstract available.

PMID:
27960168
19.

Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?

Sujobert P, Salles G, Bachy E.

Hematol Oncol Clin North Am. 2016 Dec;30(6):1163-1177. doi: 10.1016/j.hoc.2016.07.001. Review.

PMID:
27888873
20.

Conflicting Signals for Cancer Treatment.

Sujobert P, Trautmann A.

Cancer Res. 2016 Dec 1;76(23):6768-6773. Epub 2016 Nov 21.

21.

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia.

Heiblig M, Paubelle E, Plesa A, Geay MO, Manzoni D, Gazzo S, Tigaud I, Callet-Bauchu E, Huet S, Salles G, Thomas X, Hayette S, Sujobert P.

Blood. 2017 Jan 5;129(1):128-131. doi: 10.1182/blood-2016-09-741355. Epub 2016 Nov 8. No abstract available.

22.

This is not an osteoclast.

Plesa A, Sujobert P.

Blood. 2016 Oct 13;128(15):1993. No abstract available.

23.

Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia.

Sujobert P, Tamburini J.

Mol Cell Oncol. 2015 Aug 27;3(4):e1071303. doi: 10.1080/23723556.2015.1071303. eCollection 2016 Jul.

24.

Idelalisib: Targeting the PI3 Kinase Pathway in Non-Hodgkin Lymphoma.

Sujobert P, Rioufol C, Salles GA.

Cancer J. 2016 Jan-Feb;22(1):12-6. doi: 10.1097/PPO.0000000000000167. Review.

PMID:
26841011
25.

This is not an erythroblast.

Plesa A, Sujobert P.

Blood. 2015 Oct 1;126(14):1729. No abstract available.

26.

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Green AS, Maciel TT, Hospital MA, Yin C, Mazed F, Townsend EC, Pilorge S, Lambert M, Paubelle E, Jacquel A, Zylbersztejn F, Decroocq J, Poulain L, Sujobert P, Jacque N, Adam K, So JC, Kosmider O, Auberger P, Hermine O, Weinstock DM, Lacombe C, Mayeux P, Vanasse GJ, Leung AY, Moura IC, Bouscary D, Tamburini J.

Sci Adv. 2015 Sep 18;1(8):e1500221. doi: 10.1126/sciadv.1500221. eCollection 2015 Sep.

27.

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.

Mestrallet F, Sujobert P, Sarkozy C, Traverse-Glehen A, Callet-Bauchu E, Magaud JP, Salles G, Baseggio L.

Cytometry B Clin Cytom. 2016 Sep;90(5):433-9. doi: 10.1002/cyto.b.21331. Epub 2015 Dec 11.

28.

[Co-activation of AMPK and mTORC1: a therapeutic application of synthetic lethality in acute myeloid leukemia].

Tamburini J, Poulain L, Bouscary D, Sujobert P.

Med Sci (Paris). 2015 Oct;31(10):836-9. doi: 10.1051/medsci/20153110009. Epub 2015 Oct 19. French. No abstract available.

29.

Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts.

Huet S, Dulucq S, Chauveau A, Ménard A, Chomel JC, Maisonneuve H, Legros L, Perrin MC, Ferrant E, Moreilhon C, Couturier MA, Sujobert P, Magaud JP, Ugo V, Chabane K, Raynaud S, Hayette S; GBMHM (Groupe des Biologistes Moléculaires des Hémopathies Malignes, French Molecular Biology Group in Hematology).

Genes Chromosomes Cancer. 2015 Oct;54(10):595-605. doi: 10.1002/gcc.22263. Epub 2015 Aug 7.

PMID:
26252834
30.

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

Jacque N, Ronchetti AM, Larrue C, Meunier G, Birsen R, Willems L, Saland E, Decroocq J, Maciel TT, Lambert M, Poulain L, Hospital MA, Sujobert P, Joseph L, Chapuis N, Lacombe C, Moura IC, Demo S, Sarry JE, Recher C, Mayeux P, Tamburini J, Bouscary D.

Blood. 2015 Sep 10;126(11):1346-56. doi: 10.1182/blood-2015-01-621870. Epub 2015 Jul 17.

31.

Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.

Sujobert P, Poulain L, Paubelle E, Zylbersztejn F, Grenier A, Lambert M, Townsend EC, Brusq JM, Nicodeme E, Decrooqc J, Nepstad I, Green AS, Mondesir J, Hospital MA, Jacque N, Christodoulou A, Desouza TA, Hermine O, Foretz M, Viollet B, Lacombe C, Mayeux P, Weinstock DM, Moura IC, Bouscary D, Tamburini J.

Cell Rep. 2015 Jun 9;11(9):1446-57. doi: 10.1016/j.celrep.2015.04.063. Epub 2015 May 21.

32.

Diagnosis of bacteremia on a blood smear.

Manzoni D, Sujobert P.

Blood. 2015 Mar 26;125(13):2173. No abstract available.

33.

A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties.

Dahmani R, Just PA, Delay A, Canal F, Finzi L, Prip-Buus C, Lambert M, Sujobert P, Buchet-Poyau K, Miller E, Cavard C, Marmier S, Terris B, Billaud M, Perret C.

Oncogene. 2015 Apr 30;34(18):2337-46. doi: 10.1038/onc.2014.182. Epub 2014 Jul 7.

PMID:
24998845
34.

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

Bisig B, de Reyniès A, Bonnet C, Sujobert P, Rickman DS, Marafioti T, Delsol G, Lamant L, Gaulard P, de Leval L.

Haematologica. 2013 Aug;98(8):1250-8. doi: 10.3324/haematol.2012.081935. Epub 2013 May 28.

35.

Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.

Marafioti T, Copie-Bergman C, Calaminici M, Paterson JC, Shende VH, Liu H, Baia M, Ramsay AD, Agostinelli C, Brière J, Clear A, Du MQ, Piccaluga PP, Masir N, Nacheva EP, Sujobert P, Shanmugam K, Grogan TM, Brooks SP, Khwaja A, Ardeshna K, Townsend W, Pileri SA, Haioun C, Linch D, Gribben JG, Gaulard P, Isaacson PG.

Histopathology. 2013 May;62(6):860-75. doi: 10.1111/his.12076. Epub 2013 Mar 20.

PMID:
23509938
36.

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.

Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W, Hartmann EM, Sujobert P, Wlodarska I, Ferry JA, Gaulard P, Ott G, Rosenwald A, Lopez-Guillermo A, Quintanilla-Martinez L, Harris NL, Jaffe ES, Siebert R, Campo E, Beà S.

Blood. 2013 Feb 21;121(8):1394-402. doi: 10.1182/blood-2012-08-452284. Epub 2012 Dec 18.

37.

Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients.

Sujobert P, Cuccuini W, Vignon-Pennamen D, Martin-Garcia N, Albertini AF, Uzunov M, Redjoul R, Dombret H, Raffoux E.

J Invest Dermatol. 2013 Apr;133(4):1111-4. doi: 10.1038/jid.2012.408. Epub 2012 Nov 29. No abstract available.

38.

Images in haematology. Bilateral adrenal chloromas.

Sujobert P, Bardet V, Bienvenu M.

Br J Haematol. 2008 Feb;140(3):254. Epub 2007 Sep 25. No abstract available.

PMID:
17894842
39.

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways.

Tamburini J, Chapuis N, Bardet V, Park S, Sujobert P, Willems L, Ifrah N, Dreyfus F, Mayeux P, Lacombe C, Bouscary D.

Blood. 2008 Jan 1;111(1):379-82. Epub 2007 Sep 18.

40.

Mesenteric ischemia in giant cell arteritis: 6 cases and a systematic review.

Sujobert P, Fardet L, Marie I, Duhaut P, Cohen P, Grange C, Gaultier JB, Arrivé L, Cabane J.

J Rheumatol. 2007 Aug;34(8):1727-32. Epub 2007 Jul 1. Review.

PMID:
17611981
41.

Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia.

Sujobert P, Bardet V, Cornillet-Lefebvre P, Hayflick JS, Prie N, Verdier F, Vanhaesebroeck B, Muller O, Pesce F, Ifrah N, Hunault-Berger M, Berthou C, Villemagne B, Jourdan E, Audhuy B, Solary E, Witz B, Harousseau JL, Himberlin C, Lamy T, Lioure B, Cahn JY, Dreyfus F, Mayeux P, Lacombe C, Bouscary D.

Blood. 2005 Aug 1;106(3):1063-6. Epub 2005 Apr 19.

Supplemental Content

Loading ...
Support Center